Show simple item record

dc.contributor.authorIşik, Metin
dc.contributor.authorKılıç, Levent
dc.contributor.authorDoğan, İsmail
dc.date.accessioned2019-12-10T11:20:20Z
dc.date.available2019-12-10T11:20:20Z
dc.date.issued2013
dc.identifier.issn0172-8172
dc.identifier.urihttps://doi.org/10.1007/s00296-011-2246-7
dc.identifier.urihttp://hdl.handle.net/11655/15312
dc.description.abstractBeh double dagger et's disease (BD) may cause uveitis and retinal vasculitis in nearly half of the patients. Uveitis is one of the most serious complications that can lead to blindness. Sildenafil (Viagra(R)) and the other phosphodiesterase type 5 (PDE5) inhibitors are the first-line options for the treatment of erectile dysfunction, but transient visual symptoms and serious ocular side effects have been reported in PDE5 inhibitor users. Herein, we report a case with BD who applied to our outpatient unit with recurrent uveitis after sildenafil therapy.
dc.language.isoen
dc.publisherSpringer Heidelberg
dc.relation.isversionof10.1007/s00296-011-2246-7
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatology
dc.titleRecurrent Uveitis Due To Sildenafil Usage in a Patient With Beh Double Dagger Et'S Disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRheumatology International
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume33
dc.identifier.issue3
dc.identifier.startpage803
dc.identifier.endpage803
dc.description.indexWoS


Files in this item

This item appears in the following Collection(s)

Show simple item record